Concepedia

Publication | Open Access

Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma

51

Citations

50

References

2021

Year

Abstract

NCT01876212.

References

YearCitations

Page 1